Opportunity ID: 203773

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-13-007
Funding Opportunity Title: Early-Stage Pharmacological Validation of Novel Targets and Accompanying Pre-Therapeutic Leads for Diseases of Interest to the NIDDK (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Oct 10, 2012
Last Updated Date:
Original Closing Date for Applications: Mar 07, 2016
Current Closing Date for Applications: Mar 07, 2016
Archive Date: Apr 07, 2016
Estimated Total Program Funding:
Award Ceiling: $500,000
Award Floor:

Eligibility

Eligible Applicants: County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
For profit organizations other than small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal governments (Federally recognized)
Special district governments
Public housing authorities/Indian housing authorities
Small businesses
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Public and State controlled institutions of higher education
Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The overarching goal of this Funding Opportunity Announcement (FOA) is to promote translation of basic science research into knowledge and tools that can be utilized to provide strong justification for later-phase drug discovery and development efforts in areas relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. This includes obesity, diabetes and related aspects of endocrinology and metabolism, digestive diseases, liver diseases, nutrition, kidney and urological diseases, hematology, and specific aspects of cystic fibrosis. For additional information on disease areas of interest to the NIDDK, please see http://www2.niddk.nih.gov/Research/ .

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-13-007.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.847 ADOBE-FORMS-B2 Adobe-Forms-B2 PKG00151050 Jan 05, 2013 Sep 24, 2013 View
93.847 FORMS-C Use for due dates after 9/24/2013 PKG00180624 Sep 08, 2013 Mar 07, 2016 View

Package 1

Mandatory forms

203773 RR_SF424_1_2-1.2.pdf

203773 PerformanceSite_1_4-1.4.pdf

203773 RR_OtherProjectInfo_1_3-1.3.pdf

203773 RR_KeyPersonExpanded_1_2-1.2.pdf

203773 PHS398_CoverPageSupplement_1_4-1.4.pdf

203773 PHS398_ResearchPlan_1_3-1.3.pdf

203773 PHS398_Checklist_1_3-1.3.pdf

Optional forms

203773 RR_SubawardBudget30-1.2.pdf

203773 PHS398_ModularBudget_1_2-1.2.pdf

203773 RR_Budget-1.1.pdf

203773 PHS_CoverLetter_1_2-1.2.pdf

Package 2

Mandatory forms

203773 RR_SF424_2_0-2.0.pdf

203773 PHS398_ResearchPlan_2_0-2.0.pdf

203773 PHS398_CoverPageSupplement_2_0-2.0.pdf

203773 RR_KeyPersonExpanded_2_0-2.0.pdf

203773 RR_OtherProjectInfo_1_3-1.3.pdf

203773 PerformanceSite_2_0-2.0.pdf

Optional forms

203773 RR_SubawardBudget30_1_3-1.3.pdf

203773 PlannedReport-1.0.pdf

203773 PHS398_CumulativeInclusionReport-1.0.pdf

203773 PHS398_ModularBudget_1_2-1.2.pdf

203773 RR_Budget_1_3-1.3.pdf

2025-07-11T07:48:59-05:00

Share This Post, Choose Your Platform!

About the Author: